646 related articles for article (PubMed ID: 26164356)
1. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
[TBL] [Abstract][Full Text] [Related]
3. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
Gan T; Liao B; Xu G
J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
[TBL] [Abstract][Full Text] [Related]
4. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
5. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
[TBL] [Abstract][Full Text] [Related]
6. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus.
Harada K; Sumida K; Yamaguchi Y; Akai Y
Clin Nephrol; 2014 Aug; 82(2):107-14. PubMed ID: 24985951
[TBL] [Abstract][Full Text] [Related]
8. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S
J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058
[TBL] [Abstract][Full Text] [Related]
9. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
12. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population.
Raghav A; Ahmad J; Noor S; Alam K; Mishra BK
Diabetes Metab Syndr; 2018 May; 12(3):381-385. PubMed ID: 29396252
[TBL] [Abstract][Full Text] [Related]
13. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
[TBL] [Abstract][Full Text] [Related]
14. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.
Vijayaraghavan B; Padmanabhan G; Ramanathan K
Afr Health Sci; 2020 Mar; 20(1):308-313. PubMed ID: 33402919
[TBL] [Abstract][Full Text] [Related]
15. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
17. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Intern Med; 2011; 50(1):23-9. PubMed ID: 21212569
[TBL] [Abstract][Full Text] [Related]
18. Distinct biomarker roles for HbA
Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
[TBL] [Abstract][Full Text] [Related]
19. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
20. Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
Shima K; Chujo K; Yamada M; Komatsu M; Noma Y; Mizuguchi T
Ann Clin Biochem; 2012 Jan; 49(Pt 1):68-74. PubMed ID: 22194360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
